» Articles » PMID: 35626075

Risk of Complications in Patients Undergoing Completion Thyroidectomy After Hemithyroidectomy for Thyroid Nodule with Indeterminate Cytology: An Italian Multicentre Retrospective Study

Abstract

There is still controversy as to whether patients undergoing a completion thyroidectomy after a hemithyroidectomy for a thyroid nodule with an indeterminate cytology have a comparable, increased or decreased risk of complications compared to those submitted to primary thyroid surgery. The main aim of this study was to investigate this topic. Patients undergoing a thyroidectomy for thyroid nodular disease with an indeterminate cytology in four high-volume thyroid surgery centres in Italy, between January 2017 and December 2020, were retrospectively analysed. Based on the surgical procedure performed, four groups were identified: the TT Group (total thyroidectomy), HT Group (hemithyroidectomy), CT Group (completion thyroidectomy) and HT + CT Group (hemithyroidectomy with subsequent completion thyroidectomy). A total of 751 patients were included. As for the initial surgery, 506 (67.38%) patients underwent a total thyroidectomy and 245 (32.62%) a hemithyroidectomy. Among all patients submitted to a hemithyroidectomy, 66 (26.94%) were subsequently submitted to a completion thyroidectomy. No statistically significant difference was found in terms of complications comparing both the TT Group with the HT + CT Group and the HT Group with the CT Group. The risk of complications in patients undergoing a completion thyroidectomy after a hemithyroidectomy for a thyroid nodule with an indeterminate cytology was comparable to that of patients submitted to primary thyroid surgery (both a total thyroidectomy and hemithyroidectomy).

Citing Articles

Comparison of clinicopathological characteristics and prognosis between primary squamous cell carcinoma of the thyroid and squamous cell carcinoma combined with papillary thyroid carcinoma.

Yan W, Chen H, Lin X, Zhou R, Zhao F, Su J Front Endocrinol (Lausanne). 2025; 15:1514268.

PMID: 39882267 PMC: 11774738. DOI: 10.3389/fendo.2024.1514268.


A multivariable model of ultrasound and biochemical parameters for predicting high-volume lymph node metastases of papillary thyroid carcinoma with Hashimoto's thyroiditis.

Liu X, Yin H, Shen H, Wang X, Zhang Z, Yuan X Front Endocrinol (Lausanne). 2025; 15:1501142.

PMID: 39866732 PMC: 11757122. DOI: 10.3389/fendo.2024.1501142.


Case report: A case of lateral neck mass: ectopic thyroid carcinoma or lymph node metastasis?.

Wei X, Yu P, Duan C, Zhong J, Wu X, Xiao S Front Oncol. 2025; 14():1501297.

PMID: 39839801 PMC: 11746009. DOI: 10.3389/fonc.2024.1501297.


Optimal Surgical Approaches for Thyroid Cancer: A Comparative Analysis of Efficacy and Complications.

Aras A, Karayil A Med Sci Monit. 2024; 30:e942619.

PMID: 38973140 PMC: 11302178. DOI: 10.12659/MSM.942619.


Prospective application of a prediction model for lateral lymph node metastasis in papillary thyroid cancer patients with central lymph node metastasis.

Ma Y, Li Y, Zheng L, He Q Front Endocrinol (Lausanne). 2024; 14:1283409.

PMID: 38239987 PMC: 10795756. DOI: 10.3389/fendo.2023.1283409.


References
1.
Conzo G, Avenia N, Ansaldo G, Calo P, De Palma M, Dobrinja C . Surgical treatment of thyroid follicular neoplasms: results of a retrospective analysis of a large clinical series. Endocrine. 2016; 55(2):530-538. DOI: 10.1007/s12020-016-0953-2. View

2.
Papale F, Cafiero G, Grimaldi A, Marino G, Rosso F, Mian C . Galectin-3 expression in thyroid fine needle cytology (t-FNAC) uncertain cases: validation of molecular markers and technology innovation. J Cell Physiol. 2012; 228(5):968-74. DOI: 10.1002/jcp.24242. View

3.
Dobrinja C, Samardzic N, Giudici F, Raffaelli M, De Crea C, Sessa L . Hemithyroidectomy versus total thyroidectomy in the intermediate-risk differentiated thyroid cancer: the Italian Societies of Endocrine Surgeons and Surgical Oncology Multicentric Study. Updates Surg. 2021; 73(5):1909-1921. DOI: 10.1007/s13304-021-01140-1. View

4.
Sessa L, De Crea C, Zotta F, Cerviere M, Gallucci P, Pennestri F . Post-thyroidectomy hypocalcemia: Is a routine preferable over a selective supplementation?. Am J Surg. 2021; 223(6):1126-1131. DOI: 10.1016/j.amjsurg.2021.10.015. View

5.
Rosato L, De Crea C, Bellantone R, Brandi M, De Toma G, Filetti S . Diagnostic, therapeutic and health-care management protocol in thyroid surgery: a position statement of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB). J Endocrinol Invest. 2016; 39(8):939-53. DOI: 10.1007/s40618-016-0455-3. View